CHARLES RIVER LABORATORIES INTERNATIONAL, INC. Finance Lease, Right-of-Use Asset, after Accumulated Amortization
CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (CRL) had Finance Lease, Right-of-Use Asset, after Accumulated Amortization of $24.66 million as of 2025-12-27, per its 10-K filed 2026-02-18.
Financial Statements › Balance Sheet › Assets › Assets, Noncurrent
us-gaap:FinanceLeaseRightOfUseAsset · last filed 2026-02-18
- 2025-12-27: Finance Lease, Right-of-Use Asset, after Accumulated Amortization $24.66M.
- 2024-12-28: Finance Lease, Right-of-Use Asset, after Accumulated Amortization $28.90M.
- 2023-12-30: Finance Lease, Right-of-Use Asset, after Accumulated Amortization $29.42M.
- 2022-12-31: Finance Lease, Right-of-Use Asset, after Accumulated Amortization $31.88M.
| Period end | Finance Lease, Right-of-Use Asset, after Accumulated Amortization |
|---|---|
| 2025-12-27 | $24.66M 10-K · filed 2026-02-18 |
| 2024-12-28 | $28.90M 10-K · filed 2026-02-18 |
| 2023-12-30 | $29.42M 10-K · filed 2025-02-19 |
| 2022-12-31 | $31.88M 10-K · filed 2024-02-14 |
| 2021-12-25 | $29.44M 10-K · filed 2023-02-22 |
| 2021-09-25 | $30.39M 10-Q · filed 2021-11-03 |
| 2021-06-26 | $31.68M 10-Q · filed 2021-08-04 |
| 2021-03-27 | $31.44M 10-Q · filed 2021-05-04 |
| 2020-12-26 | $31.61M 10-K · filed 2022-02-16 |
| 2020-09-26 | $30.25M 10-Q · filed 2020-10-29 |
| 2020-06-27 | $30.23M 10-Q · filed 2020-08-05 |
| 2020-03-28 | $30.86M 10-Q · filed 2020-05-07 |
| 2019-12-28 | $32.52M 10-K · filed 2021-02-17 |
| 2019-09-28 | $32.08M 10-Q · filed 2019-11-06 |
| 2019-06-29 | $32.78M 10-Q · filed 2019-07-31 |
| 2019-03-30 | $30.77M 10-Q · filed 2019-05-07 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Medpace Holdings, Inc. (MEDP) | United States | $17.316B | 30.09 |
| INCYTE CORP (INCY) | United States | $24.855B | 13.14 |
| Absci Corp (ABSI) | United States | $1.775B | -14.92 |
| OmniAb, Inc. (OABI) | United States | $0.698B | -8.05 |
| NRC HEALTH (NRC) | United States | $0.450B | 42.50 |
| MAXCYTE, INC. (MXCT) | United States | $0.124B | -3.68 |
| bioAffinity Technologies, Inc. (BIAF) | United States | $0.063B | |
| OneMedNet Corp (ONMD) | $0.042B | ||
| iSpecimen Inc. (ISPC) | United States | $0.003B | |
| FOXO TECHNOLOGIES INC. (FOXO) | United States | $0.000B | -277.71 |